Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,604.50
Bid: 1,604.00
Ask: 1,604.50
Change: -5.50 (-0.34%)
Spread: 0.50 (0.031%)
Open: 1,611.50
High: 1,615.50
Low: 1,599.50
Prev. Close: 1,610.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: ITV drops as UK stocks retreat from 14-year high

Wed, 14th May 2014 11:50

- ITV leads fallers after underwhelming Q1- Markets pull back from highest level since 1999- BoE strikes dovish tone in Inflation Report- Compass, Mondi rise strongly after updatestechMARK 2,797.20 -0.25%FTSE 100 6,862.96 -0.15%FTSE 250 16,008.81 -0.19%UK stocks were in negative territory on Wednesday as the FTSE 100 retreated from a 14-year high the previous session, with ITV leading the decline after it underwhelmed with a trading update.London's benchmark index was down 0.15% at 6,863 by midday after hitting 6,873.08 on Tuesday, its best finish since reaching a record closing high of 6,930 at the end of December 1999. "Although upward progress has stalled for the moment, with 6,850 behind, it seems the index is finally about to break out of the trading range that has held it in check for the past few months," said Brenda Kelly, Chief Market Strategist at IG.Despite the slight pull-back this morning, losses were trimmed slightly after the Bank of England struck a dovish tone in its Inflation Report as it attempted to quell expectations for the first rate rise.Governor Mark Carney said the central bank is still in no rush to tighten policy with "significant slack remain[ing] in the labour market". He said while the economy has "edged closer" to the point at which the Bank Rate will need to gradually rise, the decision "will depend on the evolution of the economy, particularly the degree of slack, the prospects for its absorption, and the broader inflation outlook".Investors were also reacting to mixed economic data from the UK this morning. The Office for National Statistics reported that the UK unemployment rate fell from 6.9% to 6.8% in the three months to March, as expected by analysts; however, average weekly earnings growth remained subdued at just 1.7%, below forecasts.ITV slumps after underwhelming Q1Television network ITV fell sharply despite a seemingly in-line first-quarter statement with total external revenues up 2%. Analyst Steve Liechti from Investec said that the update "looks OK [with ad revenues] more or less as we expected", but "some bulls may have wanted more". The stock was down over 5% by midday.In contrast, catering giant Compass rose strongly as the company hiked its interim dividend after a solid first half and unveiled a £1bn capital return to investors. "Strong cash generation has underpinned our investment in the business and our commitment to reward shareholders," said Chief Executive Richard Cousins.Paper and packaging group Mondi was also higher after delivering a 13% increase in underlying operating profits in the first quarter despite a "mixed" trading environment and flat sales volumes.UK car insurer Admiral declined after reporting a 7% drop in first-quarter revenue as premiums continued to fall.On the second-tier FTSE 250, 3i Group, Partnership Assurance, Galliford Try, Wood Group and UDG Healthcare were all performing well after impressing with trading updates.Renishaw, however, declined after the engineering group said third-quarter profits were hit by currency movements.A number of heavyweight stocks were trading lower after going ex-dividend, including Aberdeen Asset Management, GlaxoSmithKline, Shell, Glencore Xstrata, Kingfisher and J Sainsbury.FTSE 100 - RisersMondi (MNDI) 1,064.00p +3.20%Compass Group (CPG) 1,011.00p +3.11%Aggreko (AGK) 1,710.00p +1.73%IMI (IMI) 1,591.00p +1.73%Experian (EXPN) 1,077.00p +1.13%Royal Mail (RMG) 572.00p +1.06%RSA Insurance Group (RSA) 487.80p +0.97%easyJet (EZJ) 1,674.00p +0.96%HSBC Holdings (HSBA) 616.40p +0.88%Old Mutual (OML) 209.90p +0.82%FTSE 100 - FallersITV (ITV) 180.80p -5.34%Sainsbury (J) (SBRY) 327.00p -3.54%Aberdeen Asset Management (ADN) 422.60p -2.96%Ashtead Group (AHT) 838.50p -2.39%Barratt Developments (BDEV) 377.70p -2.23%Kingfisher (KGF) 409.20p -1.99%Persimmon (PSN) 1,383.00p -1.50%Barclays (BARC) 251.55p -1.49%Glencore Xstrata (GLEN) 325.80p -1.47%BG Group (BG.) 1,253.00p -1.26%FTSE 250 - Risers3i Group (III) 397.30p +5.02%Imagination Technologies Group (IMG) 207.00p +4.39%Partnership Assurance Group (PA.) 129.00p +3.86%Wood Group (John) (WG.) 790.00p +2.66%Galliford Try (GFRD) 1,212.00p +2.45%St. Modwen Properties (SMP) 381.30p +2.23%Booker Group (BOK) 153.70p +2.19%JD Sports Fashion (JD.) 1,737.00p +2.00%UDG Healthcare Public Limited Company (UDG) 366.70p +1.86%African Barrick Gold (ABG) 233.90p +1.70%FTSE 250 - FallersRenishaw (RSW) 1,729.00p -5.98%Carillion (CLLN) 354.80p -3.38%Supergroup (SGP) 1,074.00p -3.24%COLT Group SA (COLT) 140.20p -2.84%Berkeley Group Holdings (The) (BKG) 2,332.00p -2.83%Alent (ALNT) 319.70p -2.80%Bank of Georgia Holdings (BGEO) 2,438.00p -2.48%Thomas Cook Group (TCG) 179.10p -2.24%Fidessa Group (FDSA) 2,297.00p -2.05%Bellway (BWY) 1,461.00p -1.95%BC
More News
3 Jun 2024 17:19

Pharma, energy stocks drag London's FTSE 100; ECB rate cut hopes cap losses

FTSE 100 down 0.2%, FTSE 250 up 0.8%

*

Read more
3 Jun 2024 17:00

LONDON MARKET CLOSE: FTSE 100 down amid shaky start in New York

(Alliance News) - The FTSE 100 in London closed lower on Monday, marking a mixed start to June, with GSK firmly at the bottom of the index.

Read more
3 Jun 2024 14:01

GSK immunotherapy bowel cancer drug works for 100% of patients

(Alliance News) - An immunotherapy drug could spare bowel cancer patients the need for surgery and chemotherapy after results showed it was effective in 100% of cases.

Read more
3 Jun 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 up, while Labour commits to defence

(Alliance News) - Stock prices in London were up at midday, after data from S&P Global signalled a return to growth for the UK manufacturing sector.

Read more
3 Jun 2024 09:08

TOP NEWS: GSK vows to appeal adverse Delaware court ruling on Zantac

(Alliance News) - GSK PLC on Monday said it will appeal a US court ruling that it should face jury trials relating to cases concerning the heartburn drug, Zantac.

Read more
3 Jun 2024 08:37

LONDON MARKET OPEN: Stocks up amid slew of manufacturing PMIs

(Alliance News) - Stock prices in London opened higher on Monday, ahead of local purchasing managers index data, and comparative prints from several other major global economies.

Read more
3 Jun 2024 08:00

LONDON BRIEFING: FTSE 100 seen up; GSK defends ranitidine cancer claim

(Alliance News) - Stocks in London are set to open higher on Monday, ahead of a data-heavy week, kicked off by a slew of manufacturing purchasing managers' index readings.

Read more
3 Jun 2024 07:30

GSK to appeal Delaware ruling on jury trials in Zantac cancer cases

(Sharecast News) - GSK shares were down almost 10% on Monday after a US court ruled that jury trials could hear expert witnesses in 70,000 cases brought by cancer sufferers claiming its Zantac heartburn drug caused their condition.

Read more
1 Jun 2024 21:35

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
1 Jun 2024 21:07

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
31 May 2024 17:45

US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label

May 31 (Reuters) - The U.S. Food and Drug Administration approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
31 May 2024 16:01

US FDA approves Moderna's RSV vaccine, its second marketed product

May 31 (Reuters) - The U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
30 May 2024 20:56

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 30 (Reuters) - A third U.S. dairy worker tested positive for bird flu after exposure to infected cows, and was the first to suffer respiratory symptoms, U.S. officials said on Thursday in the latest expansion of the outbreak. Bird flu has been found in dairy cattle in nine states. This second case in a Michigan dairy worker was found through increased testing of people and cows in the state following the April 1 identification of a case in a Texas farm worker. Here's what you need to know about the outbreak.

WHY IS H5N1 OR BIRD FLU A CONCERN?

Read more
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more
30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.